共 38 条
[2]
[Anonymous], COMPLEXITIES COLOREC
[5]
RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2011, 29 (32)
:4286-4293
[7]
Cooper K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI [10.3310/hta14320, 10.3310/hta.14320]